JNJ vs WST · P/E 17, rev $49.37B vs P/E 35, rev $1.72B
Johnson & Johnson (JNJ) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the JNJ and WST stock pages for the full models.
Not investment advice.